Silvia Di Lodovico, Antonella Fontana, Paola Di Fermo, Firas Diban, Emanuela Di Campli, Serena Pilato, Simonetta D’Ercole, Luigina Cellini, Mara Di Giulio
{"title":"Graphene Oxide and Methylglyoxal: a combined strategy against chronic wound pathogens","authors":"Silvia Di Lodovico, Antonella Fontana, Paola Di Fermo, Firas Diban, Emanuela Di Campli, Serena Pilato, Simonetta D’Ercole, Luigina Cellini, Mara Di Giulio","doi":"10.1007/s00253-026-14050-2","DOIUrl":"10.1007/s00253-026-14050-2","url":null,"abstract":"<div><p>Chronic wound infections are difficult to treat due to the polymicrobial biofilms that delay wound healing increasing antimicrobial tolerance and limiting patient compliance. To address this challenge, we developed a non-antibiotic combination of Graphene Oxide (GO) and Methylglyoxal (MGO) (patent N. 102022000024408-Composizione per il trattamento delle infezioni a carico delle lesioni cutanee) against clinically relevant chronic wound pathogens. For the tests, clinical antimicrobial resistant <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> were used. MGO MIC was determined and the best GO + MGO combination, evaluated by using checkboard test, was tested in terms of: i) fluid membrane changes; ii) <i>S. aureus</i> and <i>P. aeruginosa</i> CFUs/mg reduction in Lubbock Chronic Wound Biofilm-LCWB, a recognized polymicrobial in vitro chronic wound biofilm model; iii) <i>P. aeruginosa</i> motility. MGO MIC values ranged from 32 to 128 mg/l. Notably, synergistic interactions between GO and MGO were observed exclusively against <i>S. aureus</i>, whereas the combinations showed additive effects against <i>P. aeruginosa</i>. The best GO + MGO (6.25 + 64 mg/l) combination increased bacterial membrane fluidity, inhibited informing and mature LCWBs by 60–80% in terms of CFU/mg and <i>P. aeruginosa</i> twitching motility. GO + MGO combination exhibited an additive antimicrobial/antibiofilm activity with a multi-target action. Overall, the GO + MGO combination, at recognized non-toxic concentrations, is a valid and innovative non-antibiotic solution for wound management affecting the polymicrobial chronic wound biofilms and <i>P. aeruginosa</i> motility.</p></div>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-14050-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149035152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aylin Nur Erkmen, Roland Ulber, Thomas Jüstel, Mirjam Altendorfner
{"title":"Fermentation-based oxalic acid production aimed at sustainable critical metal recovery from electronic waste","authors":"Aylin Nur Erkmen, Roland Ulber, Thomas Jüstel, Mirjam Altendorfner","doi":"10.1007/s00253-026-14040-4","DOIUrl":"10.1007/s00253-026-14040-4","url":null,"abstract":"<p>This study systematically investigates the biogenic production of oxalic acid (OA, H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>) via submerged fermentation to establish a sustainable reagent for critical metal recovery applications. Preliminary shake-flask experiments evaluated <i>Aspergillus niger</i> strains (ATCC 1015 and CECT 2807), optimal carbon sources, and the influence of pH adjustment. Despite inherent biological variance across replicates, <i>A. niger</i> ATCC 1015 demonstrated a superior production trajectory, yielding 71.0 ± 27.7 mM OA in 5 days. Intermittent pH adjustment above 4.0 significantly enhanced secretion to 90.4 ± 5.8 mM, while glucose was identified as the optimal carbon source (Y<sub>P/S</sub> <span>(approx )</span> 0.4 g/g). Building upon these preliminary findings, process intensification was conducted in a 10 L stirred-tank bioreactor. Transitioning to a fed-batch strategy with pulsed feeding and continuous pH control effectively contributed to substantially higher OA titers, achieving a peak OA titer of 260.1 ± 4.8 mM over 14 days. Co-production of gluconic acid and acidogenesis inhibition posed a challenge in attaining higher product yields. Collectively, these findings establish a robust, scalable bioprocess for sustainable OA generation, directly supporting its emerging application as a highly selective leaching agent for critical metal recovery from electronic waste streams.</p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-14040-4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149029724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Israa Abuobida Mohamed, Qais Al-Khawlani, Raika Milde, Niels Valentin Heise, Martin Dippe, Mohamed Nagia, Ludger A. Wessjohann, Markus Pietzsch, Bodo Moritz
{"title":"Correction: Efficient biotechnological production of N-(Hydroxycinnamoyl) tyramines by utilizing plant-derived enzymes in a bench-scale bioreactor with in situ product precipitation","authors":"Israa Abuobida Mohamed, Qais Al-Khawlani, Raika Milde, Niels Valentin Heise, Martin Dippe, Mohamed Nagia, Ludger A. Wessjohann, Markus Pietzsch, Bodo Moritz","doi":"10.1007/s00253-026-14044-0","DOIUrl":"10.1007/s00253-026-14044-0","url":null,"abstract":"","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-14044-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148987106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Rezk, Heba S. Said, Sherin M. Elfeky, Mohammed El-Mowafy, Ramadan Hassan
{"title":"Disulfiram reverses fluconazole-resistance mediated by Cdr1 in Candida albicans and interferes with biofilm formation","authors":"Ahmed Rezk, Heba S. Said, Sherin M. Elfeky, Mohammed El-Mowafy, Ramadan Hassan","doi":"10.1007/s00253-026-13977-w","DOIUrl":"10.1007/s00253-026-13977-w","url":null,"abstract":"<p>The incidence of <i>Candida albicans</i> infections has risen markedly, particularly among immunocompromised individuals and cancer patients undergoing chemotherapy. Fluconazole is commonly used as a first-line treatment for <i>C. albicans</i> infections; however, increasing clinical resistance poses a significant therapeutic challenge. As a result, developing new strategies to enhance the management of <i>C. albicans</i> infections has become critical. This study aims to assess the prevalence of azole’s resistance among clinical <i>C. albicans</i> isolates in Egypt and to evaluate disulfiram/fluconazole combination against fluconazole resistant isolates. A total of 64 <i>C. albicans</i> clinical isolates were tested for fluconazole susceptibility using disc diffusion method and broth microdilution method (alone and in combination with disulfiram). The combination of fluconazole and disulfiram was further assessed using checkerboard method. The expression levels of resistance determinants were analyzed using RT-PCR. Molecular docking was used for further analysis. Sixteen isolates (25%) were resistant to fluconazole. Combination with subinhibitory concentration of disulfiram reduced the minimum inhibitory concentration (MIC) of fluconazole in resistant isolates (2–128 fold). Checkerboard assay revealed that fluconazole/disulfiram combination was mostly synergistic. In fluconazole-resistant isolates, <i>Cdr1</i> was overexpressed, whereas disulfiram (at subinhibitory concentration) has triggered its downregulation. Docking studies showed that disulfiram may compete with ATP for binding and may disrupt fluconazole's interaction with <i>Cdr1</i>. Additionally, disulfiram exhibited a potent anti-biofilm activity against the tested <i>C. albicans</i> isolates. Fluconazole/disulfiram combination appears to be a promising approach for overcoming fluconazole resistance in <i>C. albicans</i>. Further studies are needed to validate this finding and explore its clinical potential.</p><p>•<i> Fluconazole/disulfiram combination is a promising approach to overcome fluconazole resistance in C. albicans</i></p><p>• <i>Disulfiram triggered downregulation of Cdr1 expression in fluconazole-resistant C. albicans.</i></p><p>• <i>Disulfiram competes with ATP for Cdr1 binding, disrupting fluconazole-Cdr1 interaction.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-13977-w.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148954622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maximilian Hilkmann, Norma Welsch, Max Fabian Felle, Thomas Schweder, Mathis Appelbaum
{"title":"An inducer-independent, single-plasmid CRISPR-Cas9 system for genome editing in Bacillus species","authors":"Maximilian Hilkmann, Norma Welsch, Max Fabian Felle, Thomas Schweder, Mathis Appelbaum","doi":"10.1007/s00253-026-14030-6","DOIUrl":"10.1007/s00253-026-14030-6","url":null,"abstract":"<p>Advances in molecular biology tools are essential for streamlining and accelerating genetic engineering of cells across industrial and academic applications. While CRISPR-Cas improves genome editing efficiency, current systems have limitations and are often host specific, which restricts their versatility. This study describes a versatile CRISPR-Cas9 system for genome editing in industrially relevant <i>Bacillus</i> species. By adapting the well-established pJOE8999 vector-based CRISPR-Cas9 genome editing system, we constructed an inducer-independent, broad-host-range genome editing system. It maintains the benefits of low toxicity to the target cell and the cloning host as well as the ease to use of a single-plasmid CRISPR-Cas9 system. We utilized the constitutive Sigma70-type promoter from the conserved <i>veg</i> gene of <i>Bacillus</i>, to develop and test the suitability of promoter variants of different strengths for Cas9 expression. Successful gene deletions in three different <i>Bacillus</i> species demonstrated the versatility of the modified system for this industrially important genus. This was further confirmed by the integration of a reporter gene fusion and the introduction of a single point mutation in the genome of <i>Bacillus licheniformis</i>. This one-step CRISPR-based transformation protocol developed in this study enables fast genome editing workflows with minimal hands-on time.</p><p>• <i>Editing and screening of promoter variants for balanced Cas9 expression in Bacillus.</i></p><p>• <i>Development of a versatile inducer-independent, single-plasmid CRISPR-Cas-based system.</i></p><p>• <i>Verification of the modified CRISPR-based system for genome editing in different Bacilli.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-14030-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148981971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Synthetic consortia towards photosynthetically derived acetate for heterotrophic production of 1-butanol","authors":"Stamatina Roussou, Peter Lindblad","doi":"10.1007/s00253-026-14029-z","DOIUrl":"10.1007/s00253-026-14029-z","url":null,"abstract":"<p>Synthetic consortia is an emerging field in biotechnology, offering advantages such as division of labor between the individual members and reduced risk of contamination. Consortia combining phototrophic and heterotrophic bacteria are attractive, as phototrophs can utilize CO₂ and light energy to sustain growth. Several studies have explored such systems where sucrose is most commonly used as the provided carbon source. An alternative is acetate, a smaller two-carbon molecule produced as a by-product by many microorganisms, including the model cyanobacterium <i>Synechocystis</i> PCC 6803 (thereafter <i>Synechocystis</i>). Although acetate production during phototrophic growth is typically low, previous studies have demonstrated that metabolic engineering—specifically the introduction of phosphoketolase (PK) and overexpression of phosphotransacetylase (Pta)—enabled the development of a high-producing strain (WT_PKPa_RBS_BsPta_Δacs) capable of secreting significant levels of acetate into the medium (Roussou and Lindblad 2026). In this study, <i>Escherichia coli</i> and <i>Pseudomonas taiwanensis</i> were engineered to produce 1-butanol, an industrially relevant bulk chemical, and cultivated using acetate as the sole carbon source. These strains were then individually co-cultivated with the previously engineered <i>Synechocystis</i> strain, WT_PKPa_RBS_BsPta_Δacs, forming two distinct consortia that were maintained for 42 days. Growth dynamics were successfully monitored, and acetate concentrations in the consortia were lower than in a corresponding axenic <i>Synechocystis</i> culture. At the same time, 1-butanol production was detected in the two co-cultures, demonstrating the feasibility of coupling photosynthetically derived acetate to heterotrophic production of a value-added bulk chemical.</p><p>\u0000<b>•</b>\u0000<i>Photosynthetic/heterotrophic synthetic consortia for 1-butanol production</i>.</p><p><b>• </b><i>Engineered Synechocystis PCC 6803 cells produce acetate from CO</i><sub><i>2</i></sub>.</p><p><b>• </b><i>Modified Escherichia coli and Pseudomonas taiwanensis cells grow on acetate and produce 1-butanol</i>.</p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-14029-z.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148927476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhijian Ni, Xiaolu Yu, Qi Da, Xiaoxi Wu, ZhiDa Wei, Yulei Hu, Yao Xiao, Chunting Ye, Chunlin Deng
{"title":"Enhanced biosynthesis of full-length triple-helical human type III collagen in engineered Komagataella phaffii","authors":"Zhijian Ni, Xiaolu Yu, Qi Da, Xiaoxi Wu, ZhiDa Wei, Yulei Hu, Yao Xiao, Chunting Ye, Chunlin Deng","doi":"10.1007/s00253-026-13996-7","DOIUrl":"10.1007/s00253-026-13996-7","url":null,"abstract":"<p>Fibrillar type III collagen, characterized by a distinct triple helix structure, is a critical structural component of the mammalian extracellular matrix (ECM). Its unique mechanical properties and biological functions make it a highly valuable biomaterial for medical applications. However, the limited availability of natural human type III collagen (hCOL3) and the defects of animal-derived sources necessitate sustainable alternatives. Here, we developed an integrated molecular engineering strategy for the efficient production of full-length recombinant human type III collagen (rhCOL3) in <i>Komagataella phaffii</i>. The N- and C-terminal propeptides of the rhCOL3α1 chain were rationally redesigned to preserve its intrinsic capability for triple helix formation. Synergistic co-expression of human P4Hαβ and <i>Bacillus anthracis</i>-derived BaP4H achieved a proline hydroxylation level of 52.88%, enabling the stable assembly of rhCOL3 procollagen homotrimers (> 300 kDa). Subsequent optimization, including high-copy-number strain screening, signal sequence substitution (with Ost1 identified as optimal), and co-expression of the molecular chaperones (e.g., BCY1 and ERO1), significantly enhanced productivity. The engineered strain achieved a rhCOL3 procollagen yield of 430 mg/L in a 5-L fed-batch bioreactor. The purified rhCOL3 exhibited a stable triple helix conformation, a melting temperature of 38.87 °C, and the ability to self-assemble into fibrils with a characteristic D-banding pattern. Biological assays confirmed that the rhCOL3 promotes cell proliferation, adhesion, and migration at levels comparable to those of natural collagen. This study establishes a promising platform for the industrial-scale production of bioactive, triple-helical human collagen.</p><p>• <i>Synergistic P4Hαβ and BaP4H co-expression achieves 52.88% Hyp level and Tm 38.87 °C.</i></p><p>• <i>Ost1 and Bcy1 co-expression elevated rhCOL3 yield to 430 mg/L in a 5-L bioreactor.</i></p><p>• <i>Purified rhCOL3 self-assembles into D-banded fibrils resembling native collagen.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-13996-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149126358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Identification and characterization of TrxA: a novel bacterial thioredoxin–metallothionein chimera","authors":"Annamaria Vitiello, Luciano Pirone, Martina Filocaso, Gabriella Fiorentino, Emilia Pedone, Danila Limauro","doi":"10.1007/s00253-026-14002-w","DOIUrl":"10.1007/s00253-026-14002-w","url":null,"abstract":"<p>Heavy metals (HMs) are naturally occurring elements which can be essential, such as zinc, copper, and iron, or non-essential, including cadmium, mercury, and lead. While essential metals serve as cofactors in critical enzymatic processes, elevated concentrations of both essential and non-essential HMs pose severe toxicity risks, primarily through oxidative stress, disruption of metal homeostasis, and biomolecular damage. Microorganisms have evolved diverse mechanisms to cope with metal-induced stress, including metal sequestration, enzymatic transformation, efflux systems, and surface immobilization. Among these, metallothioneins (Mts) are small, cysteine-rich proteins capable of high-affinity metal binding, contributing to cellular detoxification. Although Mts have been extensively studied in eukaryotes, knowledge of bacterial Mts remains limited, with characterized examples largely confined to cyanobacteria and a few other bacterial species. In this study, we identified a novel hybrid protein, TrxA, from <i>Runella aurantiaca</i>, containing a thioredoxin (Trx) domain fused to a Mt domain. The presence of the Trx domain may confer improved stability and solubility, supporting potential recombinant applications. In fact, the recombinant protein, named TrxMt, was heterologously expressed in <i>Escherichia coli</i>, displaying both disulfide-reducing activity and heavy metal–binding capability. Notably, TrxMt expression enhanced bacterial tolerance to multiple HMs, demonstrating its functional relevance in vivo. These findings expand the understanding of bacterial Mt diversity and suggest that TrxMt is a promising candidate for the bioremediation of heavy metal–contaminated environments, combining metal detoxification with favorable biochemical properties for industrial and environmental applications.</p><p>• <i>Identification of TrxA, a novel hybrid thioredoxin–metallothionein in R. aurantiaca</i></p><p>• <i>Recombinant protein TrxMt shows reductase activity and binds HMs</i></p><p>• <i>Overexpression of TrxMt enhances tolerance to different HMs in E. coli</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-14002-w.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148975700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maike Laura Karcher, Annette Siskowski, Chantal Müller, Laura Engel, Vincent Franz, Susanne H. Kirsch, Birthe Sandargo, Tanja Schneider, Gabriele Bierbaum
{"title":"Construction of a novel reporter strain indicating inhibition of cell wall biosynthesis","authors":"Maike Laura Karcher, Annette Siskowski, Chantal Müller, Laura Engel, Vincent Franz, Susanne H. Kirsch, Birthe Sandargo, Tanja Schneider, Gabriele Bierbaum","doi":"10.1007/s00253-026-14013-7","DOIUrl":"10.1007/s00253-026-14013-7","url":null,"abstract":"<p>The WalRK two-component system monitors cell wall biosynthesis, and its activity decreases when biosynthesis is inhibited. As WalRK is essential for many Gram-positive bacteria, including <i>Staphylococcus aureus</i> and <i>Bacillus subtilis</i>, directly inhibiting WalK would disrupt cell wall biosynthesis and result in cell death. This study presents the construction of new reporter strains with two WalRK-dependent promoters: P<i>iseA</i> and P<i>ssaA</i>. These reporter strains enable indirect in vivo measurement of WalRK activity based on luminescence. We evaluated these reporters in combination with the established P<i>liaI</i> reporter system, which is regulated by LiaRS, in order to improve the identification of cell wall inhibitors during the screening of natural products. The WalRK-dependent P<i>iseA</i> reporter yielded specific responses to almost all known cell wall biosynthesis inhibitors, including β-lactams, tunicamycin, glycopeptides, daptomycin, and fosfomycin, with no discernible response to other antibiotic classes. Furthermore, combining the P<i>liaI</i> reporter system with the P<i>iseA</i> reporter enhanced the range of potential cell wall inhibitors that could be detected. Deleting the gene of the eukaryotic-like Ser/Thr kinase PrkC increased the P<i>iseA</i> signal obtained with certain antibiotics, as well as after a longer incubation period. Additionally, deletion of <i>prkC</i> lowered P<i>liaI</i> expression in the presence of lipid II-targeting antibiotics. Screening natural products with an unknown mode of action identified several compounds that elicited vancomycin-like patterns with the reporter systems, indicating potential cell wall inhibitory activity. Overall, combining WalRK and LiaRS reporters enables a rapid, complementary evaluation of cell wall stress responses, providing a powerful method for discovering new cell wall-targeting antibiotics.</p><p>• <i>The PiseA/PssaA reporters enable continuous in vivo observation of WalRK activity</i></p><p>• <i>Cell envelope stress responses are differentially sensed by WalRK and LiaRS</i></p><p>• <i>The PiseA reporter strain detects nearly all cell wall biosynthesis inhibitors</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-14013-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148838265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Israa Abuobida Mohamed, Qais Al-Khawlani, Raika Milde, Niels Valentin Heise, Martin Dippe, Mohammed Nagia, Ludger A. Wessjohann, Markus Pietzsch, Bodo Moritz
{"title":"Efficient biotechnological production of N-(Hydroxycinnamoyl)tyramines by utilizing plant-derived enzymes in a bench-scale bioreactor with in situ product precipitation","authors":"Israa Abuobida Mohamed, Qais Al-Khawlani, Raika Milde, Niels Valentin Heise, Martin Dippe, Mohammed Nagia, Ludger A. Wessjohann, Markus Pietzsch, Bodo Moritz","doi":"10.1007/s00253-026-13997-6","DOIUrl":"10.1007/s00253-026-13997-6","url":null,"abstract":"<p>The efficient recovery of plant polyphenolic bioactives is facing technological challenges of low concentrations and complex mixtures starting from plant tissue. In the search of alternatives, we developed a high-yield biotechnological production process for hydroxycinnamic acid–tyramine conjugates in <i>Escherichia coli</i> by converting soluble substrates into insoluble products. A recombinant plant-enzyme cascade was established by co-expression of <i>Arabidopsis thaliana</i> 4-coumarate:CoA ligase and <i>Solanum tuberosum</i> hydroxycinnamoyl-CoA:tyramine <i>N</i>-(hydroxycinnamoyl)transferase. We overcame initial enzymatic limitations by developing a temperature adapted and sequentially phased bioprocess on a 1 L reactor scale. With 5 mM/h substrate supply rate we achieved 31.9 g/L (102 mM) of feruloyltyramine (FerT), 14.4 g/L (50.7 mM) coumaroyltyramine, and 14.6 g/L (46.5 mM) isoferuloyltyramine with a space time yield of 1.75 g *L<sup>−1</sup> *h<sup>−1</sup> FerT. The vast majority of the product was obtained as filterable precipitate, simplifying the downstream process compared to classical procedures. Washed filter cake from a FerT production after filtration via 16–40 µm glass filter, showed 99% mass content of FerT. Product identity was confirmed by NMR after recrystallization. The newly developed process is robust, cost-effective and scalable, paving the way for commercial applications of biotechnologically produced hydroxycinnamic acid–tyramines.</p><p>• <i>Plant derived enzymes expressed at low temperature enable high productivity</i></p><p>• <i>In situ precipitated product is readily filtered from fermentation broth</i></p><p>• <i>Carbon transfer rate mirrors toxicity of phenolics and guide process optimization</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"110 1","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-026-13997-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148824426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}